10x Genomics (TXG) Inventory Average (2019 - 2026)

10x Genomics has disclosed Inventory Average across 8 years of filings, most recently posting $53.1 million for Q2 2026.

• In Q2 2026, Inventory Average fell 26.15% year-over-year to $53.1 million; the TTM figure through Jun 2026 stood at $53.1 million (down 26.15% YoY), while the FY2025 annual figure was $69.7 million, down 11.07% from the prior year.
• Inventory Average came in at $53.1 million for Q2 2026 at 10x Genomics, down from $54.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $91.2 million in Q3 2024 to a low of $53.1 million in Q2 2026.
• Average Inventory Average over 5 years is $74.2 million, with a median of $77.9 million recorded in 2023.
• Year-over-year, Inventory Average surged 80.62% in 2022 and plunged 33.22% in 2025.
• Over 5 years, Inventory Average stood at $80.1 million in 2022, then fell by 3.52% to $77.3 million in 2023, then climbed by 14.57% to $88.6 million in 2024, then sank by 33.22% to $59.1 million in 2025, then declined by 10.31% to $53.1 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $53.1 million in Q2 2026, $54.9 million in Q1 2026, and $59.1 million in Q4 2025.